Consortium to Develop Fully Implantable Brain-Computer Interface to Enable Communication for People with Paralysis

A research consortium led by the UMC Utrecht Brain Center (the Netherlands) in collaboration with Graz University of Technology (Austria), the Wyss Center for Bio and Neuroengineering (Switzerland) and CorTec (Germany) is to receive a grant through the European Innovation Council (EIC) Pathfinder Challenge mechanism.

The researchers aim to develop a unique fully implantable Brain-Computer Interface (BCI) system for people with locked-in syndrome (LIS) - a condition in which paralysis severely limits communication. The BCI will be unprecedented in its small size, wireless and powered via induction so will not require batteries. Suitable for use at home, it will be capable of decoding speech in real-time to enable people with LIS to communicate with family and caregivers.

The project will further develop the Wyss Center’s fully implantable wireless ABILITY system to connect to customized electrocorticography (ECoG) electrode grids, developed by CorTec, that detect brain signals from the surface of the brain. The ambitious timeline aims for full implant development and verification in the first two years of the project, with the second two years focusing on clinical studies and algorithm improvements to restore communication in locked-in patients with amyotrophic lateral sclerosis (ALS) or brainstem stroke. ALS is a progressive neurodegenerative disease in which people gradually lose the ability to move and talk, eventually all means of communication are lost, leaving patients isolated. Brainstem stroke can render people unable to speak or move, without recovery.

"As a first step to enable the patients to interact with the system, we will set up the decoding for mouse clicks and cursor control from intended movements, which we have shown to be feasible in previous research," explains Prof. Dr. Gernot Müller-Putz, Head of the Institute of Neural Engineering and its associated Laboratory of Brain-Computer Interfaces at the Graz University of Technology.

"Our BCI system will go far beyond current technology," says Prof. Nick Ramsey from the UMC Utrecht Brain Center, the Netherlands, who coordinates the project. "We want to create a sustainable, high-resolution BCI by combining state-of-the-art hardware and software based on artificial intelligence (AI)."

"This new project builds on the promising preliminary data from our clinical study enabling communication with a completely locked-in participant, and our pre-clinical study currently underway with the wireless, implantable ABILITY device." said Dr. Jonas Zimmermann, Senior Neuroscientist at the Wyss Center. "In this project we will record from a larger area of the brain and explore new decoding algorithms that have the potential to tackle important clinical and social needs for people with ALS but also for those with other neurological conditions that impair movement and communication."

Dr. Tracy Laabs, Chief Development Officer at the Wyss Center, is excited: "After several years of prototype developments, this project will allow us to make the crucial final steps that will bring our system to the patient."

The BCI system will be trialed in two people with locked-in syndrome in the home environment. The brain surface-lining electrode grids will collect high resolution neural data that will be decoded using AI algorithms to translate the brain signals to computer speech in real-time.

The research project 'Intracranial Neurotelemetry to Restore Communication' (INTRECOM) is part of the EIC Pathfinder Challenge program in which the European Innovation Council supports visionary, entrepreneurial researchers who have bold ideas for radically new technologies. The Swiss participants receive support from the Swiss State Secretariat for Education, Research and Innovation (SERI).

About the Wyss Center for Bio and Neuroengineering

The Wyss Center is an independent, non-profit, research and development organization that advances our understanding of the brain to realize therapies and improve lives.

The Wyss Center staff, together with the Center's academic, clinical and industrial collaborators, pursue innovations and new approaches in neurobiology, neuroimaging and neurotechnology.

Wyss Center advances reveal unique insights into the mechanisms underlying the dynamics of the brain and the treatment of disease to accelerate the development of devices and therapies for unmet medical needs.

The Wyss Center was established by a generous donation from the Swiss entrepreneur and philanthropist Hansjörg Wyss in 2014. Additional resources from funding agencies and other sources help the Wyss Center accelerate its mission.

http://www.wysscenter.ch

Most Popular Now

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

ChatGPT Performs as Well as Doctors for …

The artificial intelligence chatbot ChatGPT performed as well as a trained doctor in suggesting likely diagnoses for patients being assessed in emergency medicine departments, in a pilot study to be...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...

AI may Outperform Most Humans at Creativ…

Large language model (LLM) artificial intelligence (AI) chatbots may be able to outperform the average human at a creative thinking task where the participant devises alternative uses for everyday objects...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

AI and Machine Learning can Successfully…

Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and...